Eosinophilic Gastroenteritis Clinical Trial
Official title:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients With Moderately to Severely Active Eosinophilic Duodenitis Who Have an Inadequate Response With, Lost Response to, or Were Intolerant to Standard Therapies
This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult patients with active eosinophilic duodenitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03320369 -
Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis
|
N/A | |
Completed |
NCT00148603 -
Montelukast in the Treatment of Duodenal Eosinophilia
|
N/A | |
Completed |
NCT03664960 -
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 2 | |
Completed |
NCT00267475 -
Data Bank for Eosinophilic Disorders
|
N/A | |
Active, not recruiting |
NCT03678545 -
Dupilumab in Eosinophilic Gastritis
|
Phase 2 | |
Terminated |
NCT01814059 -
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
|
Phase 1 | |
Active, not recruiting |
NCT05214768 -
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
|
Phase 3 | |
Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
Completed |
NCT03496571 -
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
|
Phase 2 | |
Recruiting |
NCT02523118 -
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
|
||
Completed |
NCT05251909 -
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
|
Phase 3 | |
Completed |
NCT05439772 -
Examining the Effect of Ondansetron on Bowel Prep Success
|
Phase 4 | |
Completed |
NCT00266565 -
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT05199532 -
Eosinophilic Gastrointestinal Disorders Registry
|
||
Terminated |
NCT01212016 -
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
|
N/A | |
Completed |
NCT02897271 -
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
|